These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18030326)

  • 1. Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets.
    Heiny AT; Miotto O; Srinivasan KN; Khan AM; Zhang GL; Brusic V; Tan TW; August JT
    PLoS One; 2007 Nov; 2(11):e1190. PubMed ID: 18030326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.
    Tan PT; Heiny AT; Miotto O; Salmon J; Marques ET; Lemonnier F; August JT
    PLoS One; 2010 Jan; 5(1):e8754. PubMed ID: 20090904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation and variability of dengue virus proteins: implications for vaccine design.
    Khan AM; Miotto O; Nascimento EJ; Srinivasan KN; Heiny AT; Zhang GL; Marques ET; Tan TW; Brusic V; Salmon J; August JT
    PLoS Negl Trop Dis; 2008 Aug; 2(8):e272. PubMed ID: 18698358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.
    Alexander J; Bilsel P; del Guercio MF; Marinkovic-Petrovic A; Southwood S; Stewart S; Ishioka G; Kotturi MF; Botten J; Sidney J; Newman M; Sette A
    Hum Immunol; 2010 May; 71(5):468-74. PubMed ID: 20156506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability.
    Tan PT; Khan AM; August JT
    Hum Vaccin; 2011 Apr; 7(4):402-9. PubMed ID: 21471731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design.
    Chong LC; Khan AM
    BMC Genomics; 2019 Dec; 20(Suppl 9):921. PubMed ID: 31874646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly conserved influenza T cell epitopes induce broadly protective immunity.
    Eickhoff CS; Terry FE; Peng L; Meza KA; Sakala IG; Van Aartsen D; Moise L; Martin WD; Schriewer J; Buller RM; De Groot AS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5371-5381. PubMed ID: 31331771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage-specific epitope profiles for HPAI H5 pre-pandemic vaccine selection and evaluation.
    Qiu X; Duvvuri VR; Gubbay JB; Webby RJ; Kayali G; Bahl J
    Influenza Other Respir Viruses; 2017 Sep; 11(5):445-456. PubMed ID: 28715148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice.
    Alexander J; Bilsel P; del Guercio MF; Stewart S; Marinkovic-Petrovic A; Southwood S; Crimi C; Vang L; Walker L; Ishioka G; Chitnis V; Sette A; Assarsson E; Hannaman D; Botten J; Newman MJ
    Vaccine; 2010 Jan; 28(3):664-72. PubMed ID: 19895924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
    Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.
    Tutykhina I; Esmagambetov I; Bagaev A; Pichugin A; Lysenko A; Shcherbinin D; Sedova E; Logunov D; Shmarov M; Ataullakhanov R; Naroditsky B; Gintsburg A
    PLoS One; 2018; 13(1):e0191574. PubMed ID: 29377916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.
    Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J
    PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.
    Lim WC; Khan AM
    BMC Genomics; 2018 Jan; 19(Suppl 1):42. PubMed ID: 29363421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Nieuwkoop NJ; Spronken MI; van de Vijver DA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2016 Jan; 90(2):1009-22. PubMed ID: 26537686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
    Hassan AO; Amen O; Sayedahmed EE; Vemula SV; Amoah S; York I; Gangappa S; Sambhara S; Mittal SK
    PLoS One; 2017; 12(10):e0186244. PubMed ID: 29023601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets.
    Wu KW; Chien CY; Li SW; King CC; Chang CH
    Genomics; 2012 Aug; 100(2):102-9. PubMed ID: 22698979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive global amino acid sequence analysis of PB1F2 protein of influenza A H5N1 viruses and the influenza A virus subtypes responsible for the 20th-century pandemics.
    Pasricha G; Mishra AC; Chakrabarti AK
    Influenza Other Respir Viruses; 2013 Jul; 7(4):497-505. PubMed ID: 22788742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.
    Shahsavandi S; Ebrahimi MM; Sadeghi K; Mahravani H
    Virol Sin; 2015 Jun; 30(3):200-7. PubMed ID: 25894902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
    Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
    J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.